News & Updates

$Infliximab cost-effective for refractory Kawasaki disease$

Infliximab cost-effective for refractory Kawasaki disease

18 Jun 2022

For patients with Kawasaki disease (KD) refractory to initial treatment such as steroids, immunosuppressors and intravenous immunoglobulins, infliximab treatment may be a cost-effective option, reports a recent study.

Infliximab cost-effective for refractory Kawasaki disease

18 Jun 2022

Vascular dysfunction persists following nonpharmacological BP reduction

17 Jun 2022

Individuals with hypertension experience persistent vascular dysfunction at both the conduit and microvascular levels even when their blood pressure (BP) is acutely reduced by a nonpharmacological approach, reports a study.

Vascular dysfunction persists following nonpharmacological BP reduction

17 Jun 2022

Hypertension a risk factor for infective endocarditis

17 Jun 2022

Elevated blood pressure levels appear to contribute to a dose-dependent increase in the risk of developing infective endocarditis, as shown in a study.

Hypertension a risk factor for infective endocarditis

17 Jun 2022

GALACTIC-HF: Omecamtiv mecarbil benefit on CV events more pronounced in patients with low BP?

16 Jun 2022 by

The benefits of the selective cardiac myosin activator omecamtiv mecarbil on the risk of cardiovascular (CV) events in patients with heart failure with reduced ejection fraction (HFrEF) may be more evident in the difficult-to-treat population of patients with low systolic blood pressure (SBP), according to results of the phase III GALACTIC-HF trial presented at the Heart Failure 2022 annual congress.

GALACTIC-HF: Omecamtiv mecarbil benefit on CV events more pronounced in patients with low BP?

16 Jun 2022

Rheumatoid arthritis linked to increased risk of out-of-hospital cardiac arrest among women

15 Jun 2022

Out-of-hospital cardiac arrest (OHCA) tend to occur at a higher rate among patients with rheumatoid arthritis (RA), and this risk increase is especially pronounced in women but not observed in men, a study has found.

Rheumatoid arthritis linked to increased risk of out-of-hospital cardiac arrest among women

15 Jun 2022

Orthostatic hypotension ups mortality risk in geriatric outpatients

14 Jun 2022

Older outpatients with delayed/prolonged orthostatic hypotension (DPOH) are at higher risk of mortality, reveals a study. The magnitude of both systolic and diastolic OH is also associated with increased death.

Orthostatic hypotension ups mortality risk in geriatric outpatients

14 Jun 2022

Beta-blocker use reduces daily physical activity

14 Jun 2022

Treatment with beta-blockers in hypertension may decrease daily physical activity but not maximal exercise performance, a study has found.

Beta-blocker use reduces daily physical activity

14 Jun 2022

Amiodarone use may reduce survival in continuous‐flow left ventricular assist device recipients

14 Jun 2022

For patients who have undergone continuous‐flow left ventricular assist device (CF‐LVAD) implantation, treatment with amiodarone may do more harm than good, with a recent study showing that it contributes to increased risk of mortality.

Amiodarone use may reduce survival in continuous‐flow left ventricular assist device recipients

14 Jun 2022

Previous pre-eclampsia tied to early coronary atherosclerosis

12 Jun 2022

Coronary atherosclerosis is slightly more prevalent among younger women with previous pre-eclampsia than age- and parity-matched counterparts from the general population, reveals a recent study. After adjustment for traditional cardiovascular risk factors, pre-eclampsia remains an independent risk factor.

Previous pre-eclampsia tied to early coronary atherosclerosis

12 Jun 2022

Smokers who quit remain at risk of heart failure for decades

11 Jun 2022

Cigarette smokers have an excess risk of heart failure (HF) with reduced ejection fraction (HFrEF) and HF with preserved ejection fraction (HFpEF), confirms a recent study. Additionally, those who quit smoking show a reduction in HF risk, but the risk persists for a few decades.

Smokers who quit remain at risk of heart failure for decades

11 Jun 2022

News & Updates

Filter by Specialty:

Specialty:

Infliximab cost-effective for refractory Kawasaki disease

Infliximab cost-effective for refractory Kawasaki disease

Vascular dysfunction persists following nonpharmacological BP reduction

Vascular dysfunction persists following nonpharmacological BP reduction

Hypertension a risk factor for infective endocarditis

Hypertension a risk factor for infective endocarditis

GALACTIC-HF: Omecamtiv mecarbil benefit on CV events more pronounced in patients with low BP?

GALACTIC-HF: Omecamtiv mecarbil benefit on CV events more pronounced in patients with low BP?

Rheumatoid arthritis linked to increased risk of out-of-hospital cardiac arrest among women

Rheumatoid arthritis linked to increased risk of out-of-hospital cardiac arrest among women

Orthostatic hypotension ups mortality risk in geriatric outpatients

Orthostatic hypotension ups mortality risk in geriatric outpatients

Beta-blocker use reduces daily physical activity

Beta-blocker use reduces daily physical activity

Amiodarone use may reduce survival in continuous‐flow left ventricular assist device recipients

Amiodarone use may reduce survival in continuous‐flow left ventricular assist device recipients

Previous pre-eclampsia tied to early coronary atherosclerosis

Previous pre-eclampsia tied to early coronary atherosclerosis

Smokers who quit remain at risk of heart failure for decades

Smokers who quit remain at risk of heart failure for decades